| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000044846 |
| Receipt No. | R000051221 |
| Scientific Title | Retrospective exploratory clinical study to identify epileptogenic foci by statistical analysis of electrocorticographic signals during general anesthesia in patients with intractable epilepsy (observational study) |
| Date of disclosure of the study information | 2021/07/13 |
| Last modified on | 2022/01/12 (Ver. 4) |
| Basic information | ||
| Public title | Retrospective exploratory clinical study to identify epileptogenic foci by statistical analysis of electrocorticographic signals during general anesthesia in patients with intractable epilepsy (observational study) | |
| Acronym | Retrospective exploratory clinical study to identify epileptogenic foci by statistical analysis of electrocorticographic signals during general anesthesia in patients with intractable epilepsy (observational study) | |
| Scientific Title | Retrospective exploratory clinical study to identify epileptogenic foci by statistical analysis of electrocorticographic signals during general anesthesia in patients with intractable epilepsy (observational study) | |
| Scientific Title:Acronym | Retrospective exploratory clinical study to identify epileptogenic foci by statistical analysis of electrocorticographic signals during general anesthesia in patients with intractable epilepsy (observational study) | |
| Region |
|
|
| Condition | |||
| Condition | refractory epilepsy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In this study, we analyze the effect of anesthetic agents on electroencephalography in refractory epilepsy patients equipped with chronic intracranial electrode. Our aim of this study is to examine whether it is possible to identify the epileptogenic foci of the patient using this method. Finally, it is expected that refractory epilepsy patients undergoing focal lobectomy can skip intracranial electrode placement. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | MI value at each anesthesia stage and each intracranial electrode.
The ECoG analysis period was divided into the following five anesthetic stages: [1] baseline wakefulness before the anesthetic induction; [2] first 1/3; [3] middle 1/3; [4] last 1/3 periods between the sevoflurane initiation and its concentration reaching 2.0 MAC; [5] sevoflurane 2.0 MAC maintenance. |
| Key secondary outcomes | MI value at given anesthesia stage and given intracranial electrode when the epileptigenic region and the non-epileptic region are classified |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with refractory epilepsy who are scheduled for focal resection after placement of intracranial electrode
2) Patients with obvious abnormalities in MRI in the area expected to show epileptogenicity 3) Patients with ASA-PS (American association of anesthesia physical status) 1-2 4) Patients in NCNP hospital 5) Patients achieving ILAE class 1 outcome at least six months after surgical resection |
|||
| Key exclusion criteria | 1) Patients who cannot be used sevoflurane
2) Patients who cannot be used propofol 3) The case an anesthetic other than sevoflurane, propofol, remifentanil, rocuronium is used during EEG measurement 4) Patients with ASA-PS3 or higher 5) Patients with epilepsy surgery not intended for radical surgery 6) The case does not agree with the prescribed bank consent 7) Other persons whom representative of this study consider inappropriate 8) Patients achieving ILAE class 2 or higher outcome at least six months after surgical resection |
|||
| Target sample size | 8 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Center of Neurology and Psychiatry | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 187-8551 | ||||||
| Address | 4-1-1, Ogawahigashi-cho, Kodaira-shi, Tokyo, Japan | ||||||
| TEL | 042-341-2712 | ||||||
| keikotoki@ncnp.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Center of Neurology and Psychiatry | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 187-8551 | ||||||
| Address | 4-1-1, Ogawahigashi-cho, Kodaira-shi, Tokyo, Japan | ||||||
| TEL | 042-341-2712 | ||||||
| Homepage URL | |||||||
| keikotoki@ncnp.go.jp | |||||||
| Sponsor | |
| Institute | National Center of Neurology and Psychiatry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Center of Neurology and Psychiatry |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Center of Neurology and Psychiatry |
| Address | 4-1-1, Ogawahigashi-cho, Kodaira-shi, Tokyo, Japan |
| Tel | 042-341-2712 |
| rinri-jimu@ncnp.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 8 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051221 |